Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study.
Fabrazzo M, Romano F, Arrigo M, Puca RV, Fuschillo A, De Santis V, Sampogna G, Giordano GM, Catapano F, Lo Schiavo A. Fabrazzo M, et al. Among authors: romano f. Int J Environ Res Public Health. 2022 Feb 12;19(4):2060. doi: 10.3390/ijerph19042060. Int J Environ Res Public Health. 2022. PMID: 35206248 Free PMC article.
A case of figurate urticaria by etanercept.
Sessa M, Sullo MG, Mascolo A, Cimmaruta D, Romano F, Puca RV, Capuano A, Rossi F, Schiavo AL. Sessa M, et al. Among authors: romano f. J Pharmacol Pharmacother. 2016 Apr-Jun;7(2):106-8. doi: 10.4103/0976-500X.184777. J Pharmacol Pharmacother. 2016. PMID: 27440958 Free PMC article.
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience.
Fargnoli MC, Esposito M, Dapavo P, Parodi A, Rossi M, Tiberio R, Dastoli S, Offidani AM, Argenziano G, Gisondi P, Lo Schiavo A, Loconsole F, Pella P, Bardazzi F, Cusano F, Gattoni M, Nacca M, Cannavò SP, Pellegrini C, Costanzo A; BRILLIANT Working Group. Fargnoli MC, et al. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):693-700. doi: 10.1111/jdv.16931. Epub 2020 Oct 13. J Eur Acad Dermatol Venereol. 2021. PMID: 32916767
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study.
Megna M, Balato A, Caccavale S, Cacciapuoti S, Calabrese G, Di Brizzi EV, Di Costanzo L, Manzo R, Marino V, Puca RV, Romano F, Sarno O, Scotto di Luzio G, Lembo S. Megna M, et al. Among authors: romano f. J Clin Med. 2024 Apr 26;13(9):2552. doi: 10.3390/jcm13092552. J Clin Med. 2024. PMID: 38731081 Free PMC article.
1,271 results